United States · FDA National Drug Code directory
Erythromycin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 52536-186_292b4c82-0b72-5283-e063-6394a90ad2ac
- Product NDC
- 52536-186
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- Erythromycin
- Labeler
- Wilshire Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190722
- Source listing expiry
- 20261231
Source-listed ingredients
- ERYTHROMYCIN — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-186-03) · 52536-186-03
- 100 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-186-10) · 52536-186-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →